pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

2,369 catalysts · 4,686 phase readout · 2,350 8k filing · 285 earnings · 253 pdufa · 172 phase 2 completion · 73 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 11 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 0 catalysts2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: patent expiry×type: approval×type: filing×type: 8k filing×clear all
type
  • phase readout4,686
  • 8k filing2,350
  • earnings285
  • pdufa253
  • phase 2 completion172
  • phase 1 completion73
phase 2 initiation
62
  • phase 1 initiation40
  • phase 1 2 completion35
  • phase 0 trial completion23
  • therapy area
    • Infectious Disease9
    • Ophthalmology5
    • Oncology2
    • Dermatology1
    • Pulmonology1

    Week of Apr 20, 2026

    31
    ›Apr 24, 2026patent expiry91d agoDaiichi Sankyo Co Ltd — laninamivir (Constraining Patent Expiry (Japan))laninamivir

    Therapy area: Infectious Disease, Respiratory. Indication: Asthma, Influenzavirus A Infections, Influenzavirus B Infections

    full page →laninamivir →source: globaldata
    ›Apr 24, 2026patent expiry91d agoEisai Co Ltd — lenvatinib mesylate (Constraining Patent Expiry (US))lenvatinib mesylate

    Therapy area: Gastrointestinal, Infectious Disease, Oncology. Indication: Acral Lentiginous Melanoma, Adenocarcinoma Of The Gastroesophageal Junction, Adenoid Cystic Carcinoma (ACC), Adrenocortical Carcinoma (Adrenal Cortex Cancer), Anaplastic Thyroid Cancer, Bile Duct Cancer (Cholangiocarcinoma), Bladder Cancer, Breast Cancer, Colorectal Cancer, Cutaneous Squamous Cell Carcinoma (cSCC), Endometrial Cancer, Ependymoma, Epithelial Ovarian Cancer, Esophageal Squamous Cell Carcinoma (ESCC), Ewing S

    full page →lenvatinib mesylate →source: globaldata
    ›Apr 24, 20268k filing91d agoHumacyte, Inc. (HUMA, HUMAW) — 8-K filingHumacyte, Inc.

    Items: 1.01, 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 24, 20268k filing91d ago$ALT — Altimmune, Inc. (ALT) — 8-K filingAltimmune, Inc.

    Items: 1.01, 9.01

    full page →edgar 8k ↗
    ›Apr 24, 20268k filing91d agoNEXGEL, INC. (NXGL, NXGLW) — 8-K filingNEXGEL, INC.

    Items: 3.01

    full page →edgar 8k ↗
    ›Apr 24, 20268k filing91d agoNewAmsterdam Pharma Co N.V. (NAMS, NAMSW) — 8-K filingNewAmsterdam Pharma Co N.V.

    Items: 5.02

    full page →edgar 8k ↗
    ›Apr 24, 20268k filing91d ago$PDSB — PDS Biotechnology Corp (PDSB) — 8-K filingPDS Biotechnology Corp

    Items: 8.01, 9.01

    full page →edgar 8k ↗
    ›Apr 24, 20268k filing91d ago$NVCR — NovoCure Ltd (NVCR) — 8-K filingNovoCure Ltd

    Items: 5.02, 9.01

    full page →edgar 8k ↗
    ›Apr 24, 20268k filing91d agoProfusa, Inc. (PFSA, NVACW) — 8-K filingProfusa, Inc.

    Items: 1.01, 2.03, 9.01

    full page →edgar 8k ↗
    ›Apr 24, 20268k filing91d ago$ONCO — Onconetix, Inc. (ONCO) — 8-K filingOnconetix, Inc.

    Items: 5.02, 9.01

    full page →edgar 8k ↗
    ›Apr 24, 20268k filing91d agoMedicus Pharma Ltd. (MDCX, MDCXW) — 8-K filingMedicus Pharma Ltd.

    Items: 1.01, 3.01, 9.01

    full page →edgar 8k ↗
    ›Apr 24, 20268k filing91d ago$QTTB — Q32 Bio Inc. (QTTB) — 8-K filingQ32 Bio Inc.

    Items: 8.01, 9.01

    full page →edgar 8k ↗
    ›Apr 24, 20268k filing91d agoScorpius Holdings, Inc. — 8-K filing

    Items: 5.02

    full page →edgar 8k ↗
    ›Apr 24, 20268k filing91d ago$XBIO — Xenetic Biosciences, Inc. (XBIO) — 8-K filingXenetic Biosciences, Inc.

    Items: 5.02, 9.01

    full page →edgar 8k ↗
    ›Apr 24, 20268k filing91d ago$CTXR — Citius Pharmaceuticals, Inc. (CTXR) — 8-K filingCitius Pharmaceuticals, Inc.

    Items: 1.01, 8.01, 9.01

    full page →edgar 8k ↗
    ›Apr 24, 20268k filing91d ago$APGE — Apogee Therapeutics, Inc. (APGE) — 8-K filingApogee Therapeutics, Inc.

    Items: 5.02

    full page →edgar 8k ↗
    ›Apr 24, 20268k filing91d ago$SANA — Sana Biotechnology, Inc. (SANA) — 8-K filingSana Biotechnology, Inc.

    Items: 5.02

    full page →edgar 8k ↗
    ›Apr 24, 20268k filing91d ago$TELO — Telomir Pharmaceuticals, Inc. (TELO) — 8-K filingTelomir Pharmaceuticals, Inc.

    Items: 1.01, 2.01, 3.02, 9.01

    full page →edgar 8k ↗
    ›Apr 24, 20268k filing91d agoANAPTYSBIO, INC (ANAB, ANABV) — 8-K filingANAPTYSBIO, INC

    Items: 9.01

    full page →edgar 8k ↗
    ›Apr 24, 20268k filing91d ago$CPIX — CUMBERLAND PHARMACEUTICALS INC (CPIX) — 8-K filingCUMBERLAND PHARMACEUTICALS INC

    Items: 5.07

    full page →edgar 8k ↗
    ›Apr 24, 20268k filing91d ago$ODYY — Odyssey Health, Inc. (ODYY) — 8-K filingOdyssey Health, Inc.

    Items: 1.01, 8.01, 9.01

    full page →edgar 8k ↗
    ›Apr 24, 20268k filing91d ago$NTHI — NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) — 8-K filingNEONC TECHNOLOGIES HOLDINGS, INC.

    Items: 1.01, 3.02, 9.01

    full page →edgar 8k ↗
    ›Apr 24, 20268k filing91d ago$BIOE — Bio Essence Corp (BIOE) — 8-K filingBio Essence Corp

    Items: 1.01, 9.01

    full page →edgar 8k ↗
    ›Apr 24, 20268k filing91d ago$HALO — HALOZYME THERAPEUTICS, INC. (HALO) — 8-K filingHALOZYME THERAPEUTICS, INC.

    Items: 5.03, 9.01

    full page →edgar 8k ↗
    ›Apr 24, 20268k filing91d ago$MGTX — MeiraGTx Holdings plc (MGTX) — 8-K filingMeiraGTx Holdings plc

    Items: 1.01, 9.01

    full page →edgar 8k ↗
    ›Apr 24, 20268k filing91d ago$INDP — Indaptus Therapeutics, Inc. (INDP) — 8-K filingIndaptus Therapeutics, Inc.

    Items: 5.02, 9.01

    full page →edgar 8k ↗
    ›Apr 24, 20268k filing91d ago$IRD — Opus Genetics, Inc. (IRD) — 8-K filingOpus Genetics, Inc.

    Items: 2.03

    full page →edgar 8k ↗
    ›Apr 24, 20268k filing91d ago$LUCD — Lucid Diagnostics Inc. (LUCD) — 8-K filingLucid Diagnostics Inc.

    Items: 7.01, 8.01, 9.01

    full page →edgar 8k ↗
    ›Apr 24, 20268k filing91d ago$GRDX — GridAI Technologies Corp. (GRDX) — 8-K filingGridAI Technologies Corp.

    Items: 2.04

    full page →edgar 8k ↗
    ›Apr 25, 2026patent expiry90d agoStemline Therapeutics Inc — SL-901 (Constraining Patent Expiry (Japan))SL-901

    Therapy area: Oncology, Undisclosed. Indication: Lung Cancer, Solid Tumor, Unspecified Rare Disease

    full page →SL-901 →source: globaldata
    ›Apr 26, 2026patent expiry89d agoBlue Blood Biotech Corp — BB-101 (Constraining Patent Expiry (Japan))BB-101

    Therapy area: Dermatology. Indication: Diabetic Foot Ulcers

    full page →BB-101 →source: globaldata

    Week of Apr 27, 2026

    19
    ›Apr 27, 2026patent expiry88d agoBill & Melinda Gates Medical Research Institute — SB-692342 (Constraining Patent Expiry (Japan))SB-692342

    Therapy area: Infectious Disease. Indication: Pulmonary Tuberculosis

    full page →SB-692342 →source: globaldata
    ›Apr 27, 20268k filing
    ← prev
    page 1 of 48
    next →
    88d ago
    $ADGM — Adagio Medical Holdings, Inc. (ADGM) — 8-K filing

    Items: 8.01, 9.01

    full page →edgar 8k ↗
    ›Apr 27, 20268k filing88d ago$OGN — Organon & Co. (OGN) — 8-K filing

    Items: 1.01, 5.02, 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 27, 20268k filing88d ago$ARMP — Armata Pharmaceuticals, Inc. (ARMP) — 8-K filing

    Items: 5.02, 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 27, 20268k filing88d ago$ETON — Eton Pharmaceuticals, Inc. (ETON) — 8-K filing

    Items: 8.01, 9.01

    full page →edgar 8k ↗
    ›Apr 27, 20268k filing88d ago$GRCE — Grace Therapeutics, Inc. (GRCE) — 8-K filing

    Items: 8.01, 9.01

    full page →edgar 8k ↗
    ›Apr 27, 20268k filing88d ago$FULC — Fulcrum Therapeutics, Inc. (FULC) — 8-K filing

    Items: 1.02, 2.02, 5.02, 9.01

    full page →edgar 8k ↗
    ›Apr 27, 20268k filing88d ago$SI — SHOULDER INNOVATIONS, INC. (SI) — 8-K filing

    Items: 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 27, 20268k filing88d ago$SGMT — Sagimet Biosciences Inc. (SGMT) — 8-K filing

    Items: 2.02, 7.01, 8.01, 9.01

    full page →edgar 8k ↗
    ›Apr 27, 20268k filing88d ago$CRMD — CorMedix Inc. (CRMD) — 8-K filing

    Items: 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 27, 20268k filing88d ago$MMED — MiniMed Group, Inc. (MMED) — 8-K filing

    Items: 7.01

    full page →edgar 8k ↗
    ›Apr 27, 20268k filing88d ago$ORKA — Oruka Therapeutics, Inc. (ORKA) — 8-K filing

    Items: 7.01, 8.01, 9.01

    full page →edgar 8k ↗
    ›Apr 27, 20268k filing88d ago$SGMT — Sagimet Biosciences Inc. (SGMT) — 8-K filing

    Items: 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 27, 20268k filing88d ago$TERN — Terns Pharmaceuticals, Inc. (TERN) — 8-K filing

    Items: 7.01, 8.01, 9.01

    full page →edgar 8k ↗
    ›Apr 27, 20268k filing88d ago$ONCY — ONCOLYTICS BIOTECH INC (ONCY) — 8-K filing

    Items: 8.01

    full page →edgar 8k ↗
    ›Apr 27, 20268k filing88d agoXOMA Royalty Corp (XOMA, XOMAO, XOMAP) — 8-K filing

    Items: 1.01, 8.01, 9.01

    full page →edgar 8k ↗
    ›Apr 27, 20268k filing88d ago$MIRM — Mirum Pharmaceuticals, Inc. (MIRM) — 8-K filing

    Items: 8.01

    full page →edgar 8k ↗
    ›Apr 27, 20268k filing88d ago$CMPX — Compass Therapeutics, Inc. (CMPX) — 8-K filing

    Items: 7.01, 8.01, 9.01

    full page →edgar 8k ↗
    ›Apr 27, 20268k filing88d ago$BMRN — BIOMARIN PHARMACEUTICAL INC (BMRN) — 8-K filing

    Items: 1.01, 2.01, 2.03, 7.01, 9.01

    full page →edgar 8k ↗
    $PDSB0.7155-5.86%
    $HUMAW0.00990.00%
    $NAMSW19.38-5.74%
    $NVCR15.57-2.69%
    $NXGLW0.03080.00%
    $ALT2.8100-0.35%
    $ONCO0.8801-1.08%
    $PFSA1.9000-5.00%
    $MDCX0.3755+0.27%
    $QTTB15.08-2.14%
    $XBIO2.6700-1.11%
    $SANA3.1200-1.27%
    $CTXR0.5623+3.08%
    $TELO1.0600-1.85%
    $APGE134.08-0.09%
    $ANABV43.80+1.86%
    $CPIX7.1150-9.36%
    $ODYY0.00600.00%
    $NTHI3.6700+8.90%
    $BIOE0.27000.00%
    $HALO77.82-0.99%
    $MGTX12.16-2.88%
    $INDP2.6450+4.96%
    $LUCD0.9450-2.24%
    $IRD3.0500-0.33%
    $GRDX3.4200-3.39%